Experts agree that school reopening programs are more successful when combined with COVID-19 testing protocols. Past school reopening plans focused mainly on screening for COVID-19 symptoms.

However, recent studies have pointed out the insufficiency of symptom only screenings for COVID-19 because nearly 40% of COVID-19 cases are asymptomatic.

SeraParma™ IgM tests for both symptomatic and asymptomatic COVID-19 infections at a low cost ranging from $30-$50.

By providing rapid testing results within 20 minutes and with high sensitivity, SeraParma™ can prevent more than 80% of new transmissions.